Tags:BiopharmaDevelopmentDrug
Drug discovery and development company focused on infectious diseases and the treatment of drug-resistant bacteria
Location: United States, North Carolina, Chapel Hill
Total raised: $15M

Investors 2

Funding Rounds 2

DateSeriesAmountInvestorsDeal News
09.09.2014-$10M-aislingcap...
17.08.2011-$5M-medcitynew...

Mentions in press and media 22

DateTitleDescriptionCategoryAuthorSource
09.09.2014Cempra, In...Toyama Receives Regulatory Cle...--aislingcap...
09.09.2014Cempra get...Interestingly, antibiotic resi...--medcitynew...
30.03.2012Antibiotic...“Every day has value,” Fernand...--medcitynew...
07.03.2012No IPO for...But the public markets have re...--medcitynew...
03.02.2012Cempra IPO...Cempra has two clinical-stage ...--medcitynew...
31.01.2012Cempra IPO...Cempra’s two lead drug candida...--medcitynew...
16.01.2012IPO for Ce...Proceeds from the Cempra IPO w...--medcitynew...
13.10.2011Cempra IPO...While the antibiotic market is...--medcitynew...
15.09.2011Cempra ant...But levofloxacin carries safet...--medcitynew...
17.08.2011Antibacter...A Cempra spokesman said the co...--medcitynew...
Show more